Bio-Techne launches ultra-sensitive neurodegenerative disease assays on Ella platform

MedPal AI announces approval to supply Eli Lilly medicines in UK

Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme

Insilico Medicine agrees drug development collaboration with Qilu Pharmaceutical Group

HanchorBio partners with WuXi Biologics for development and manufacturing of next-gen bi- and multi-functional fusion programmes

United Therapeutics reports positive phase 1 data for bioengineered liver in acute liver failure

Sarepta reports positive three-year EMBARK results for ELEVIDYS in ambulatory Duchenne patients

BioArctic partner Eisai secures FDA priority review for Leqembi Iqlik subcutaneous starting dose

Scancell secures FDA clearance for Phase 3 melanoma trial of iSCIB1+

BioCryst Pharmaceuticals acquires Astria Therapeutics

Insilico Medicine's ISM8969 receives US FDA IND approval for Parkinson's Disease

Bausch Health reports RED-C Phase 3 trials failed to meet primary endpoint

ImmunityBio reports promising survival and immune recovery in recurrent glioblastoma study

Sanofi advances amlitelimab toward global filings after phase 3 results in atopic dermatitis

Trevi Therapeutics reports key Phase 2b CORAL trial results for oral nalbuphine ER